PATENT CLAIM ANALYSIS

Application Number: 15509466
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "049000"]

Abstract:
The present invention relates to cysteamine, cystamine, or derivatives thereof, for use in the treatment and/or prevention of infection caused by the bacterium,  Mycobacterium  spp., in particular  Mycobacterium abscessus , or a disease or condition associated therewith.

Claim (Index 5):
The amino thiol compound of  claim 4  wherein the infection, or disease or condition associated therewith, is selected from the group consisting of respiratory infections, infections in cystic fibrosis, chronic obstructive pulmonary disease (COPD), skin and wound infections, middle-ear infections, gastrointestinal tract infections, peritoneal membrane infections, urogenital tract infections, oral soft tissue infections, formation of dental plaque, eye infections, endocarditis and infections of indwelling medical devices.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.30303
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14460953', '15669289', '14675218', '13945257', '13349789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7566499507556912
- 35 USC 102 Novelty (BERT): 0.4862493348517434
- Combined Prediction Score: 0.7296098891652965
- Mean Citation Score: 192.27938
- Max Citation Score: 197.42651
- Similarity Product: 139.15224291494192

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test